Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

AVIR Atea Pharmaceuticals

5.690
+0.090+1.61%
Close 09/30 16:00 ET
5.660
-0.030-0.53%
Post Mkt Price 09/30 16:55 ET
High
5.875
Open
5.590
Turnover
3.24M
Low
5.570
Pre Close
5.600
Volume
563.47K
Market Cap
473.74M
P/E(TTM)
43.77
52wk High
46.910
Shares
83.26M
P/E(Static)
4.15
52wk Low
5.310
Float Cap
392.42M
Bid/Ask %
66.67%
Historical High
94.174
Shs Float
68.97M
Volume Ratio
0.81
Historical Low
5.310
Dividend TTM
--
Div Yield TTM
--
P/B
0.72
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.82%
Amplitude
5.45%
Avg Price
5.743
Lot Size
1
Float Cap
392.42M
Bid/Ask %
66.67%
Historical High
94.174
Shs Float
68.97M
Volume Ratio
0.81
Historical Low
5.310
Dividend TTM
--
P/B
0.72
Dividend LFY
--
Turnover Ratio
0.82%
Amplitude
5.45%
Avg Price
5.743
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
CEO: Dr. Jean-Pierre Sommadossi,PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...